Design for Implementation: The Future of Trauma Research & Clinical Guidance
YEAR 3 – February 25-26, 2026
Read the Conference Summary
The three-year Design for Implementation: The Future of Trauma Research & Clinical Guidance conference series wrapped up in early 2026. Leaders from trauma surgery, emergency medicine, health systems, implementation science, data science and patient advocacy met for the third and final conference, led by PI Lacey LaGrone, MD, MPH, MA, FACS.
The meeting brought together this diverse group of clinicians, researchers, technologists and policy thinkers to explore a rapidly changing landscape: how artificial intelligence, evolving research ecosystems and global care realities are reshaping the way clinical guidance is created, disseminated and applied at the bedside.
Across the two-day meeting, one message emerged clearly: the future of trauma clinical guidance will depend on collective action. There are unprecedented opportunities to improve care, but only if they are guided by thoughtful governance, inclusive design and shared commitment to patient benefit. The Design for Implementation conference series represents an important step toward the collaborative journey.
Read the Conference Agenda
Conference Recordings
Participant Bios
Reading Materials
YEAR 2 – February 19-20, 2025
This second year of the DFI conference series built on last year’s work to arrive at a shared understanding of shortcomings in the ways that guidance is developed, disseminated and implemented. Participants this year began to co-design and beta-test remedies to what plagues the system, with the ultimate objective of improving patient outcomes.
“It takes 17 years on average for research findings to make their way into clinical practice,” said Eileen Bulger, MD, ACS Medical Director of Trauma Programs, in her opening remarks. “But even then, a hospital may or may not have access to the research, and practitioners may or may not be able to find it in time to help the patient in front of them.”
Lacey LaGrone, MD, MPH, conference PI, believes that now is the right time in history to solve this problem—with the evolution of generative AI and FHIR/HL7 standardization, the rise of open access platforms, and aligned incentives among the rural U.S., military and global majority healthcare systems. “We’ve gotten as much as we possibly can out of the current system, said LaGrone, “Now, it needs to change.”
Read the full conference summary: HERE
Conference Recordings
Participant Bios
Reading Materials
Trauma Clinical Guidance Repository
The Minimum Viable Product (MVP) defined at the first DFI conference included: “Develop a consolidated, coordinated, accessible (free/offline), easy-to-use platform to house existing guidance—recommended to be used in every hospital, every time, every patient.”
The digital consulting firm, Tactuum, developed an app featuring 200+ searchable guidance resources in multiple formats. The links below take you to the beta version of a repository online (left), or to the appropriate app store to download it on your phone (right). This effort is a work in progress. Please give your feedback and recommendations in the app by clicking the plus sign and then “Send Feedback,” or feel free to email Lacey LaGrone ([email protected]) directly with thoughts or suggestions.
Trauma Guidance Repository Online
Quris Trauma Guidance App
Scan for Apple
Scan for Android
YEAR 1 – February 20-21, 2024
Conference Recordings
Participant Bios
Reading Materials
SUPPORT THIS WORK
Thank you for thoughtfully considering support for this action-oriented conference series. Your investment will help to facilitate real breakthroughs in the implementation of trauma center best practices that result in better care for all of us and save lives!
| SEE OUR SPONSORSHIP OPPORTUNITIES |
Funding for this conference was made possible [in part] by grant number 1R13HS028940-01A1 from the Agency for Healthcare Research and Quality (AHRQ). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
|
|
